|
1 |
16 11 2026 |
NPPA allows discontinuation of 14 scheduled formulations in first three months of FY 27 |
Pharmabiz |
India |
|
2 |
16 11 2026 |
Haryana regulator backs draft G.S.R. 955(E) mandating authorized persons for pharma batch clearances |
Pharmabiz |
India |
|
3 |
16 11 2026 |
Indian biopharma looks for effective regulations to fast-track approvals & accelerate market entry: Manoj Panicker |
Pharmabiz |
India |
|
4 |
16 11 2026 |
Need for strengthening India’s API base to rebuild APIs and KSMs: Bhavin Mehta |
Pharmabiz |
India |
|
5 |
16 11 2026 |
India’s pharma industry shift towards high-value drugs to boost demand for agrochemicals and specialty chemicals |
Health world (Economic Times) |
India |
|
6 |
16 11 2026 |
A bitter pill:Indian Pharma industry , trump's tariff and a congress that campaigned on cheaper care |
Times of India |
India |
|
7 |
16 11 2026 |
Sun Pharma eyes $4 Bn loan for Organon buy |
Health world (Economic Times) |
India |
|
8 |
14 11 2026 |
SEC refuses phase III trial waiver for Sun Pharma's semaglutide of synthetic origin for additional indications |
Pharmabiz |
India |
|
9 |
14 11 2026 |
NPPA orders strict monitoring of 30% trade margin cap on 137 cancer drugs, warns of penal action |
Medical Dialogues |
India |
|
10 |
13 11 2026 |
Ayush Quality Mark to help Indian traditional medicine firms meet global quality requirements: Anil Jauhri |
Pharmabiz |
India |
|
11 |
13 11 2026 |
SC reserves verdict on trade margin cap, puts entire non-scheduled drug market and DPCO framework on edge |
Pharmabiz |
India |
|
12 |
13 11 2026 |
Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia |
Pharmabiz |
India |
|
13 |
13 11 2026 |
DoP calls for proposals under SMDI to reduce import dependence |
Pharmabiz |
India |
|
14 |
13 11 2026 |
NPPA sets Sun Pharma's Diclofenac gel price at Rs.6.25 per gram |
Medical Dialogues |
India |
|
15 |
13 11 2026 |
Centre orders strict monitoring of cancer drug prices following ceiling of mark-ups |
Health world (Economic Times) |
India |
|
16 |
13 11 2026 |
Aurobindo arm recalls antibiotic lot in US over detection of glass particles |
Health world (Economic Times) |
India |
|
17 |
13 11 2026 |
Aurobindo arm recalls antibiotic lot in US over detection of glass particles |
Health world (Economic Times) |
India |
|
18 |
13 11 2026 |
PLI scheme delivers strong gains in electronics, white goods, pharma; newer sectors still in early stages: NITI Aayog |
Fortune India |
India |
|
19 |
12 11 2026 |
Ayush exports, imports decline in H1 FY27 |
Pharmabiz |
India |
|
20 |
12 11 2026 |
CDSCO asks States and UTs to onboard Sugam Labs portal |
Pharmabiz |
India |